Ben Bulkley on Invitrogen s Evolving Effort to Reach Potential Clients | GenomeWeb

Last week, Invitrogen reported its first-quarter 2005 results, posting a 4-percent gain in organic revenue year-over-year (see BioCommerce Week 5/5/2005). During a conference call following the release, the firm revealed that it had recently embarked on an effort to visit a large number of "key" potential customers around the globe.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: transcriptome patterns of Zika-infected cells, updated Comparative Toxicogenomics Database, and more.

BMJ study says that about half of former hematology-oncology regulators now work for industry.

Science should wish PhDs who leave academia well, a Nature editorial says.

New York-based doctors announce the birth of a baby boy whose parents underwent mitochondrial transfer therapy, New Scientist reports.